Prof. Dongbing Zhao 赵东兵
Chief Physician, Professor
Department of Pancreatic and Gastric Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of gastric cancer, gastrointestinal stromal tumors, pancreatic cancer, gastrointestinal and pancreatic neuroendocrine tumors, and colorectal cancer, with a focus on laparoscopic minimally invasive surgery.
Dr. Zhao holds a PhD in Oncology from Peking Union Medical College (1998) and has nearly 30 years of experience treating abdominal tumors. A visiting scholar at the UK Institute of Cancer Research and Hong Kong Christian Hospital, Dr. Zhao specializes in minimally invasive surgery for gastric and colorectal cancers, safe pancreatic surgery, and comprehensive care for neuroendocrine tumors.
Professional roles
- Chair, Neuroendocrine Tumor Professional Committee, China Medical Promotion Association
- Deputy Director, Pancreatic and Gastric Surgery Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
- Standing Committee Member, Surgical Professional Committee (Gastrointestinal Group), Beijing Medical Association
- Deputy Chair, Gastrointestinal Tumor Professional Committee, National Telemedicine and Internet Center
Name order: in Chinese the family name comes first (Zhao Dongbing). Papers usually list the name as Dongbing Zhao or Zhao D.
Selected publications
17 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- World J Gastrointest Surg, 2023 (senior author): Analysis of textbook outcomes for ampullary carcinoma patients following pancreaticoduodenectomy. PubMed 37969713
- Am J Cancer Res, 2023 (senior author): At least 16 lymph nodes are recommended to examine during pancreaticoduodenectomy in ampullary adenocarcinoma. PubMed 36777520
- J Transl Med, 2022 (senior author): Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing. PubMed 36474268
- Curr Oncol, 2022 (senior author): Impact of Diabetes on Short-Term and Long-Term Outcomes of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy. PubMed 36290805
- Am J Cancer Res, 2022 (senior author): Long-term survival and pattern of recurrence in ampullary adenocarcinoma patients after curative Whipple's resection: a retrospective cohort study in the National Cancer Center in China. PubMed 36119819
- Front Oncol, 2021 (senior author): Development and Validation of a New Lymph Node Ratio-Based Staging System for Ampullary Carcinoma After Curative Pancreaticoduodenectomy. PubMed 35127524
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion